GlaxoSmithKline To Pay $75M To Settle Patent Suit
GlaxoSmithKline has agreed to pay $75 million dollars to settle a drug patent lawsuit brought by a consumer group that had accused the U.K. drug maker of using illegal tactics to...To view the full article, register now.
Already a subscriber? Click here to view full article